By Maggie Fox
The Food and Drug Administration approved the prescription cannabidiol medicine Monday to treat rare and severe forms of epilepsy.
FDA Commissioner Dr. Scott Gottlieb also issued an immediate statement saying this wasn’t an approval of marijuana, in general — and said anyone wanting to use cannabis-based products to treat disease must prove they are safe and that they work.
The new drug, Epidiolex, is a formulation of cannabidiol — CBD for short. It’s derived from cannabis but doesn’t contain the THC that recreational users value for providing “highs.”